Ligand validation:5OSW

DIU: 2-HYDROXY-3,5-DIIODO-BENZOIC ACID

DIU is a Ligand Of Interest in 5OSW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5OSW_DIU_A_602	98%	10%	0.071	0.995	3.47	1.04	9	1	2	0	100%	1
5OSW_DIU_A_601	98%	46%	0.077	0.996	1.59	0.55	2	-	3	0	100%	1
5OSW_DIU_A_603	97%	26%	0.082	0.998	2.28	0.9	4	1	0	0	100%	1
5OSW_DIU_A_606	92%	43%	0.103	0.994	1.74	0.55	2	-	0	0	100%	1
5OSW_DIU_A_605	90%	21%	0.1	0.984	2.62	0.87	4	1	0	0	100%	0.7
5OSW_DIU_A_604	84%	31%	0.126	0.99	2.1	0.77	4	-	5	0	100%	0.6
4LUH_DIU_A_601	72%	8%	0.127	0.953	1.66	3.21	3	10	2	0	100%	1
3B56_DIU_B_3000	100%	40%	0.049	0.998	0.87	1.51	-	5	0	0	100%	0.5
2BXL_DIU_A_3001	98%	31%	0.067	0.991	1.95	0.94	4	-	1	0	100%	1
4J2V_DIU_A_602	95%	21%	0.09	0.996	1.9	1.6	5	3	4	0	100%	1
4JK4_DIU_A_604	76%	16%	0.147	0.985	3.02	0.91	6	-	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.